Researchers evaluate treatment guidelines for African Americans with asthma – News-Medical.net

Researchers evaluate treatment guidelines for African Americans with asthma
News-Medical.net
In a first-of-its-kind clinical trial, asthma researchers at University Hospitals Rainbow Babies & Children's Hospital (UH Rainbow) will evaluate treatment guidelines for African American children and young adults with asthma. "Each year African

View full post on asthma – Google News

Mobile clinics provide only asthma treatment for some Detroit children – The Detroit News

Mobile clinics provide only asthma treatment for some Detroit children
The Detroit News
Between 18-20 percent of Detroit Public School children have asthma, according to Ora Beard, principal of Dixon Educational Learning Academy in Detroit. Often left untreated because families don't have access to health care and schools don't have

and more »

View full post on asthma – Google News

Teva’s DuoResp Spiromax receives EC marketing authorization for treatment of … – News-Medical.net

Teva's DuoResp Spiromax receives EC marketing authorization for treatment of
News-Medical.net
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) announced today that the European Commission has granted marketing authorization for DuoResp Spiromax® for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) …
Teva Gets Approval To Market DuoResp Spiromax In EuropeRTT News

all 2 news articles »

View full post on asthma – Google News

Getting treatment for asthma is difficult for children living in poverty – Michigan Radio

Getting treatment for asthma is difficult for children living in poverty
Michigan Radio
“Children in poverty are at risk because they don't have the resources to rid their homes of things like mold and moisture, so it does take a lot of other referrals to help our families to decrease the asthma symptoms in the home,” said Jackson. That's

View full post on asthma – Google News

Tiotropium as Asthma Add-On Treatment Shows Promise – Monthly Prescribing Reference

Tiotropium as Asthma Add-On Treatment Shows Promise
Monthly Prescribing Reference
Boehringer Ingelheim has announced positive results from several Phase 3 studies analyzing once-daily tiotropium (Spiriva; Boehringer Ingelheim) delivered via the Respimat inhaler as an add-on treatment for asthma patients who remain symptomatic with 
Phase III studies show tiotropium delivered via Respimat inhaler proves News-Medical.net

all 4 news articles »

View full post on asthma – Google News